Geron Corp (NASDAQ:GERN)

1.41
Delayed Data
As of Jan 17
 -0.04 / -2.76%
Today’s Change
0.99
Today|||52-Week Range
2.14
+3.68%
Year-to-Date
Better Buy: Geron vs. Incyte
Jan 07 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close1.45
Today’s open1.46
Day’s range1.41 - 1.46
Volume1,282,279
Average volume (3 months)1,472,990
Market cap$281.7M
Data as of 4:00pm ET, 01/17/2020

Growth & Valuation

Earnings growth (last year)+12.66%
Earnings growth (this year)-180.00%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)+0.09%
P/E ratioNM
Price/Sales165.58
Price/Book1.48

Competitors

 Today’s
change
Today’s
% change
NEPTNeptune Wellness Sol...+0.13+4.50%
EVFMEvofem Biosciences I...-0.47-7.38%
VBIVVBI Vaccines Inc-0.15-8.43%
WVEWAVE Life Sciences L...-0.23-2.84%
Data as of 4:00pm ET, 01/17/2020

Financials

Next reporting dateMarch 16, 2020
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$1.1M
Annual profit (last year)-$27.0M
Net profit margin-2,534.43%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Menlo Park, California

Forecasts